Why Itron (ITRI) Outpaced the Stock Market Today

Itron (ITRI) shares outperformed the market, rising 2.53% versus the S&P 500's 0.94% gain, and have gained 6.22% over the past month. Upcoming earnings are projected to show a 9.92% EPS increase to $1.33, with revenue expected to rise slightly to $609.26 million; however, full-year EPS is projected to decline 3.02%, while revenue is expected to increase 0.76%. The stock currently has a Zacks Rank #3 (Hold) and trades at a forward P/E of 22.37, a discount to its industry average.

Analysis

Itron (ITRI) has recently demonstrated notable stock strength, closing at $125.04 with a +2.53% daily gain that outpaced the S&P 500, and has accumulated a 6.22% increase over the past month, surpassing both the broader market and the Computer and Technology sector. Market participants are keenly awaiting its upcoming earnings disclosure, where EPS is projected to reach $1.33, representing a 9.92% year-over-year increase, while revenue is expected to see a marginal rise of 0.03% to $609.26 million. However, the full-year outlook, according to Zacks Consensus Estimates, indicates a potential -3.02% decline in EPS to $5.45, contrasting with an anticipated +0.76% revenue growth to $2.46 billion. Recent upward revisions in analyst estimates, evidenced by the consensus EPS projection moving 0.6% higher in the last 30 days, suggest improving near-term business sentiment. Despite these positive signals and momentum, Itron currently holds a Zacks Rank of #3 (Hold). From a valuation standpoint, ITRI trades at a Forward P/E of 22.37, a slight discount to its industry's average of 23.64, and possesses a significantly more favorable PEG ratio of 0.77 compared to the industry average of 2.65, suggesting potential undervaluation relative to its earnings growth prospects. The company operates within the Electronics - Testing Equipment industry, which is positioned in the top 39% of over 250 industries, indicating a relatively robust sector environment.

Key Decisions for Investors

• Investors should closely monitor Itron's upcoming earnings release for confirmation of the projected 9.92% quarterly EPS growth and seek management commentary to clarify the outlook for the full year, particularly concerning the forecasted -3.02% EPS decline.
• The current Zacks Rank #3 (Hold) suggests a neutral stance; however, the notably attractive PEG ratio of 0.77 and recent positive EPS estimate revisions could present a compelling case for investors if upcoming earnings validate near-term growth expectations.
• Given the stock's recent outperformance and comparatively favorable valuation metrics like the PEG ratio, maintaining existing positions may be prudent while awaiting further clarity from the earnings report and subsequent analyst actions.